Skip to content

Poor CD4 cell recovery after starting HIV treatment should be a cause for concern, close monitoring needed

IAS 2011 conference: summary

Operational research: diagnostics and task-shifting

Pre-exposure prophylaxis

Retention of pre-ART patients poor in sub-Saharan Africa

Boceprevir response and resistance differs according to HCV genotype 1 subtype

Daria Hazuda from Merck. ©IAS/Marcus Rose/Worker's Photos

Valaciclovir slows HIV disease progression in pregnant and breastfeeding women

Herpes drugs and viral load: valaciclovir works better than aciclovir